Literature DB >> 11578421

Phenotypic characteristics of mononuclear cells in human ovarian tumors - with special reference to cystic and ascitic fluid.

S. Kullander1, A. Rausing.   

Abstract

The occurrence of mononuclear cells and their cell-surface phenotype was studied in cryo- and paraffin sections in 26 untreated ovarian tumors and in normal ovarian tissue. T cells (positive for CD4 or CD8 markers) were sparsely represented in all sections of normal ovarian tissue and benign ovarian tumors, and in most ovarian cancer sections. B cells were found in three malignant tumors, CD57-positive (natural killer) cells in two, and CD25 (interleukin-2 receptor)-positive cells in one. Macrophages occurred sparsely both in normal ovarian tissue and in benign and malignant ovarian tumors. One endometrioid ovarian cancer, however, manifested rich infiltration of T cells (predominantly positive for CD8 marker). Cystic fluid from malignancies manifested higher prostaglandin concentrations and total cell counts than did benign cystic fluid, but sparse lymphocytes as a rule (5-10% of the total cell count). As compared to cystic fluid, ascitic fluid had higher concentrations both of prostaglandins and cells, with up to 25% lymphocytes in connection with malignancies. Immunogenic activity thus would appear to be weak in ovarian cancer. The harvest of tumor-infiltrating lymphocytes (TIL) from cystic fluid in ovarian cancers is moderate, compared to that of tumor-associated lymphocytes (TAL) from corresponding ascitic fluid samples.

Entities:  

Year:  1994        PMID: 11578421     DOI: 10.1046/j.1525-1438.1994.04050298.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  2 in total

1.  Weapons ovarian epithelial tumors may use in immune escape: an immunohistochemical correlational study.

Authors:  Eiman Adel Hasby
Journal:  Pathol Oncol Res       Date:  2011-12-08       Impact factor: 3.201

2.  Immunophenotyping of tumor-infiltrating mononuclear cells in ovarian carcinoma.

Authors:  Thanaa el-A Helal; Ali E Khalf Alla; Mohamed A Laban; Remon M Fahmy
Journal:  Pathol Oncol Res       Date:  2004-06-09       Impact factor: 2.874

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.